Eyepoint Pharmaceuticals shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Eyepoint Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eyepoint Pharmaceuticals held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eyepoint Pharmaceuticals by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.3M | 90k | 14.24 |
| 2025-06-30 | $906k | 96k | 9.41 |
| 2025-03-31 | $470k | 87k | 5.42 |
| 2024-12-31 | $667k | 90k | 7.45 |
| 2024-09-30 | $616k | 77k | 7.99 |
| 2024-06-30 | $668k | 77k | 8.70 |
| 2024-03-31 | $1.2M | 58k | 20.67 |
| 2023-12-31 | $1.1M | 46k | 23.11 |
| 2023-09-30 | $334k | 42k | 7.99 |
| 2023-06-30 | $352k | 40k | 8.70 |
| 2023-03-31 | $115k | 39k | 2.93 |
| 2022-12-31 | $132k | 38k | 3.50 |
| 2022-09-30 | $296k | 38k | 7.90 |
| 2022-06-30 | $278k | 35k | 7.87 |
| 2022-03-31 | $358k | 30k | 12.15 |
| 2021-12-31 | $270k | 22k | 12.26 |
| 2021-09-30 | $229k | 22k | 10.40 |
| 2021-06-30 | $186k | 21k | 9.01 |